Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

MIDAZOLAM HCL 50 MG/10 ML VIAL

Midazolam hydrochloride
$0.4500per ML
DEA Schedule CIV

Strength

5 mg/mL

Manufacturer

Heritage Pharmaceuticals Inc.

NDC

23155060142

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Last Updated

2/19/2025

Active Ingredients

MIDAZOLAM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090850

On Market Since

11/7/2016

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+24.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

CLONAZEPAM 0.5 MG TABLET
Generic
00093083201•Teva Pharmaceuticals USA Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
00093083205•Teva Pharmaceuticals USA Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
00904722761•Major Pharmaceuticals
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
16729013600•Accord Healthcare Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
16729013616•Accord Healthcare Inc.
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040610•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040611•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
43547040650•Solco Healthcare US LLC
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
50268017315•AvPAK
$0.0200
per EA
CLONAZEPAM 0.5 MG TABLET
Generic
59651072201•Aurobindo Pharma Limited
$0.0200
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy